Overview of the three FDA-approved medications for opioid use disorder: methadone, naltrexone, and buprenorphine. Includes evidence supporting the medications’ effectiveness and the role of shared decision-making for choosing a medication.
Presenter: Maureen Oscadal, MPH, BSN, RN, CARN, AMB-BC
August 2024
Relevant resources:
ADAI MOUD Brochure (English) from ADAI: [ Ссылка ]
ADAI MOUD Brochure (Spanish) from ADAI: [ Ссылка ]
ADAI Guide to Talking to Someone About MOUD: [ Ссылка ]
Learn more about overdose prevention and response at [ Ссылка ]
Find more videos in this series: [ Ссылка ]
This training is funded by the State Opioid Response (SOR) grant from the Substance Abuse and Mental Health Services Administration (SAMHSA), and is provided by the University of Washington’s Addictions, Drug & Alcohol Institute.
